Literature DB >> 9149688

Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats.

K D Lake1, B R Martin, G Kunos, K Varga.   

Abstract

We previously showed that in anesthetized rats anandamide elicits bradycardia and a triphasic blood pressure response: transient hypotension secondary to a vagally mediated bradycardia, followed by a brief pressor and prolonged depressor response, the latter two effects being similar to those of delta 9-tetrahydrocannabinol (THC). The prolonged depressor but not the pressor response was reduced after alpha-adrenergic receptor blockade or cervical spinal cord transection and was inhibited by the cannabinoid type 1 (CB1) receptor antagonist SR141716A, suggesting CB1 receptor-mediated sympathoinhibition as the underlying mechanism. Here we examined the relationship between sympathetic tone and the cardiovascular effects of anandamide by testing these effects in both conscious and anesthetized, normotensive and spontaneously hypertensive rats. In urethane-anesthetized normotensive rats, SR141716A inhibited the prolonged depressor and bradycardic effects of anandamide and THC with similar potency, whereas it did not affect the pressor response to either agent. Anadamide caused similar hypotension in spontaneously breathing and in paralyzed, mechanically ventilated rats, suggesting that the hypotension is not secondary to respiratory effects. In conscious normotensive rats, anandamide elicited transient vagal activation and a brief pressor response, but the prolonged hypotensive component was absent. SR141716A potentiated and prolonged the brief pressor response to anandamide, suggesting that the depressor response may have been masked by an increased pressor response. All three phases of the anadamide response were present in both anesthetized and conscious spontaneously hypertensive rats, and the hypotensive component, inhibited by SR141716A in both, was more prolonged in the absence (> 50 minutes) than the presence (10 to 15 minutes) of anesthesia. We conclude that anandamide causes a non-CB1 receptor-mediated pressor and a CB1 receptor-mediated prolonged depressor response. The depressor response can be elicited in both conscious and anesthetized animals, but its magnitude depends on preexisting sympathetic tone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149688     DOI: 10.1161/01.hyp.29.5.1204

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  64 in total

Review 1.  The complexities of the cardiovascular actions of cannabinoids.

Authors:  Michael D Randall; David A Kendall; Saoirse O'Sullivan
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 2.  Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?

Authors:  Barbara Malinowska; Marta Baranowska-Kuczko; Eberhard Schlicker
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Endocannabinoids in cerebrovascular regulation.

Authors:  Zoltán Benyó; Éva Ruisanchez; Miriam Leszl-Ishiguro; Péter Sándor; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

4.  The cardiovascular actions of anandamide: more targets?

Authors:  Michael D Randall
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

5.  Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.

Authors:  Grzegorz Kwolek; Agnieszka Zakrzeska; Eberhard Schlicker; Manfred Göthert; Grzegorz Godlewski; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

6.  Diuretic, Natriuretic, and Vasodepressor Activity of a Lipid Fraction Enhanced in Medium of Cultured Mouse Medullary Interstitial Cells by a Selective Fatty Acid Amide Hydrolase Inhibitor.

Authors:  Zdravka Daneva; Sara K Dempsey; Ashfaq Ahmad; Ningjun Li; Pin-Lan Li; Joseph K Ritter
Journal:  J Pharmacol Exp Ther       Date:  2018-12-07       Impact factor: 4.030

Review 7.  Cannabinoid receptors and their endogenous agonist, anandamide.

Authors:  J Axelrod; C C Felder
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

8.  Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats.

Authors:  James R Padley; Qun Li; Paul M Pilowsky; Ann K Goodchild
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

9.  Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.

Authors:  Anna Pędzińska-Betiuk; Jolanta Weresa; Marek Toczek; Marta Baranowska-Kuczko; Irena Kasacka; Ewa Harasim-Symbor; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2017-05-31       Impact factor: 8.739

Review 10.  The emerging role of the endocannabinoid system in cardiovascular disease.

Authors:  Pál Pacher; Sabine Steffens
Journal:  Semin Immunopathol       Date:  2009-04-09       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.